ПРОГНОСТИЧЕСКИЕ КРИТЕРИИ ТЕЧЕНИЯ ПЛОСКОКЛЕТОЧНОГО РАКА ГОРТАНИ (ОБЗОР ЛИТЕРАТУРЫ)
https://doi.org/10.17650/2222-1468-2013-0-1-33-38
Аннотация
В обзоре дана оценка использования наиболее распространенных молекулярно-биологических маркеров для прогноза течения плоскоклеточного рака гортани. В качестве критериев предлагается использовать маркеры Ki-67 и р53, а также учитывать особенности ангиоархитектоники опухоли.
Об авторах
Н. А. Горбань
ФГБУ «Медицинский радиологический научный центр» Минздрава России, Обнинск
Россия
Россия
В. В. Попучиев
ФГБУ «Медицинский радиологический научный центр» Минздрава России, Обнинск
Россия
Россия
В. В. Барышев
ФГБУ «Медицинский радиологический научный центр» Минздрава России, Обнинск
Россия
Россия
Список литературы
1. Acikalin M.F., Oner U., Tel N. et al. Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy. Eur Arch Otorhinolaryngol 2004;261(7):376–80.
2. Alicikus Z.A., Akman F., Ataman O.U. et al. Importance of patient, tumour and treatment related factors on quality of life in head and neck cancer patients after definitive treatment. Eur Arch Otorhinolaryngol 2009 Sep;266(9):1461–8. Epub 2008 Dec 19.
3. Arisi E., Pruneri G., Carboni N. et al. Prognostic significance of P27 and cyclin D1 co-expression in laryngeal squamous cell carcinoma: possible target for novel therapeutic strategies. J Chemother 2004;16(5):3–6.
4. Ataman O.U., Bentzen S.M., Wilson G.D. et al. Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. Eur J Cancer 2004;40(18):2734–41.
5. Chen G.G., Vlantis A.C., Chak E.C. et al. The expression of Bcl-2 family proteins and spontaneous apoptosis in laryngeal carcinomas. Oncol Res 2006;16(6):273–80.
6. Cheng W., Li X., Quan C., Guo X. Role of P53, nm23 proteins and vascular endothelial growth factor in angiogenesis and metastasis of laryngeal cancer. Zhonghua Er Bi Yan Hou Ke Za Zhi 2000;35(2):147–9.
7. Ciardiello F., Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358(11):1160–74.
8. Condon L.T., Ashman J.N., Ell S.R. et al. Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int J Cancer 2002;100(4):472–5.
9. Gale N., Kambic V., Michaels L. et al. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 2000 Jul;7(4):240–51.
10. Georgiou A., Gomatos I.P., Ferekidis E. et al. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Eur J Surg Oncol 2001;27(6):574–80.
11. Georgiou A., Gomatos I.P., Pararas N.B. et al. Cell kinetics and apoptosis in laryngeal carcinoma patients. Ann Otol Rhinol Laryngol 2003;112(3):206–13.
12. Gomatos I.P., Georgiou A., Giotakis J. et al. The role of host immune response and apoptosis in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69(3):159–66.
13. Gryczyński M., Kobos J., Murlewska A., Pietruszewska W. Survival of patients with laryngeal cancer and some prognostic factors. Otolaryngol Pol 2003;57(3):329–40.
14. Gryczyński M., Kobos J., Niewiadomska H., Pietruszewska W. Assessment of cell proliferation antigen Ki- 67, protein p53 related to apoptosis and angiogenesis in laryngeal cancer. Otolaryngol Pol 2000;54(31):191–5.
15. Guo T., Sun J.W., Lv Q.P., Li X.G. Allelic imbalance onchromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa. J Laryngol Otol 2008;122(1):72–7.
16. Ioachim E., Peschos D., Goussia A. et al. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J Exp Clin Cancer Res 2004;23(2):277–83.
17. Jäckel M.C., Sellmann L., Dorudian M.A. et al. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope 2000;110(8):1339–45.
18. Kanijo T., Yokose T., Hasebe T. et al. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin Cancer Res 2000;6:3159–65.
19. Khademi B., Shirazi F. M., Vasei M. et al. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 2002 Oct 28;184(2):223–30.
20. Klatka J. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 2001;258(10):537–41.
21. Kleist B., Junghans D., Lorenz G. et al. The supplementary diagnostic power of selection immunohistochemical, molecular genetic and infective parameters in epithelial hyperplastic laryngeal lesions. Oncology 2003;65:347–54.
22. Krecicki T., Dus D., Kozlak J. et al. Quantitative evaluation of angiogenesis in laryngeal cancer by digital image measurement of the vessel density. Auris Nasus Larynx 2002;29(3):271–6.
23. Krecicki T., Jeleń M., Zalesska-Krecicka M., Szkudlarek T. Ki-67 immunostaining and prognosis in laryngeal cancer. Clin Otolaryngol Allied Sci 1998;23(6):539–42.
24. Krecicki T., Smigiel R., Fraczek M. et al. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J Laryngol Otol 2004;118(9):676–80.
25. Kropveld A., Slootweg P.J., Blankenstein M.A. et al. Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope1998;108(10):1548–52.
26. Kumar R.V., Shenoy A.M., Daniel R., Shah K.V. Cyclin D1, p53, MIB1, intratumoral microvessel density, and human papillomavirus in advanced laryngeal carcinoma: association with nodal metastasis. Otolaryngol Head Neck Surg 2004;131(4):509–13.
27. Lazaris A.Ch., Rigopoulou A., Tseleni- Balafouta S. et al. Immunodetection and clinico-pathological correlates of two tumour growth regulators in laryngeal carcinoma. Histol Histopathol 2002;17(1):131–8.
28. Li J., Tang L., Ren Z., Pan Z. Distribution and prognostic significance of microvessel density in supraglottic laryngeal squamous cell carcinomas. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2004;18(9):513–5.
29. Liu M., Lawson G., Delos M. et al. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol 2003;260(1):28–34.
30. Lu Y.Y., Shen P., Ding W. Study on the relationship between microvascular density and prognosis in laryngeal cancer. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2000;14(12):538–9.
31. Mielcarek-Kuchta D., Olofsson J., Golusinski W. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2003;260(10):549–54.
32. Morshed K., Skomra D., Korobowicz E. et al. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma. Acta Otolaryngol 2007;127(7):760–9.
33. Motamed M., Banerjee A.R., Bradley P.J., Powe D. MIB-1 and p53 expression in radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma. Clin Otolaryngol Allied Sci 2001;26(3):227–30.
34. Nadal A., Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 2003;442(1):1–7.
35. Nix P., Cawkwell L., Patmore H. et al. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer 2005;92(12):2185–9.
36. Ogawa T., Shiga K., Tateda M. et al. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment. Oncol Rep 2003;10(5):1461–6.
37. Ozdek A., Sarac S., Akyol M.U. et al. С-myc and bcl-2 expression in supraglottic squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg 2004;131(1):77–83.
38. Pastuszewski W., Dziegiel P., Krecicki T.et al. Prognostic significance ofmetallothionein, p53 protein and Ki-67antigen expression in laryngeal cancer.Anticancer Res 2007;27(1A):335–42.
39. Peschos D., Stefanou D., Vougiouklalis T.et al. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. J Exp Clin Cancer Res 2005;24(3):431–7.
40. Rodrigo J.P., Garcia-Carracedo D., Garcia L.A., Menendez S. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009;217(4):516–23.
41. Segas J.V., Lazaris A.C., Nikolopoulos T.P. et al. Cyclin D1 protein tissue detection in laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 2005;67(6):319–25.
42. Sengiz S., Pabuccuoglu U., Sarioglu S. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx. Pathol Res Pract 2004;200(3):181–8.
43. Serio G., Giardina C., Valente T. et al. Quantitative morphometrical investigation of basal cell layer in laryngeal premalignant lesions. J Exp Clin Cancer Res 2002;21(4):495–502.
44. Sittel C., Eckel H.E., Damm M. et al. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 2000;110(6):1012–7.
45. Takes R.P., Baatenburg De Jong R.J., Alles M.J. et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002;128(5):512–8.
46. Teknos T.N., Cox C., Barrios M.A. et al. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope 2002;112(5):844–51.
47. Teppo H., Soini Y., Melkko J. et al. Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, proliferation (Ki-67) and angiogenesis. APMIS 2003;111(4):451–7.
48. Trask D.K., Wolf G.T., Bradford C.R. et al. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 2002;112(4):638–44.
49. Vielba R., Bilbao J., Ispizua A. et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003;113(1):167–72.
50. Volavsek M., Bracko M., Gale N. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. J Laryngol Otol 2003;117(4):286–93.
51. World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. Barnes L., Eveson J.W., Reichart P., Sidranski D. Lyon.: IARC Press, 2005.
52. Yildirim S., Cermik H., Işitmangil T. et al. Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma. J Int Med Res 2002;30(6):597–600.
53. Yoo S.S., Carter D., Turner B.C. et al. Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation. Int J Cancer 2000;90(1):22–8.
54. Zhang L., Luan X., Pan X. et al. Measurement of microvessel density in laryngeal carcinoma and its clinical significance. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001;15(3):115–7.
55. Ziółkowski A., Olszewski W.P., Gabriel A. et al. DNA ploidy, cyclin D1, bcl-2 and lymphocytic infiltration of the tumor microenvironment as prognostic factors in laryngeal cancer patients. Pol J Pathol 2005;56(4):171–8.
56. Барышев В.В., Андреев В.Г., Попучие в В.В. Современные аспекты изучения респираторного папилломатоза. Ч. 1. Этиология, патогенез, диагностика. Сибирский онкологический журнал 2009; 5(35):67–72.
57. Горбань Н.А. Тен В.П., Панкрато в В.А. Ангиогенез в плоскоклеточном раке гортани и его прогностическое значение. Вопросы онкологии 2008;54(6):732–76.
58. Горбань Н.А., Тен В.П., Панкрато в В.А. Экспрессия антигена Ki-67 и белка p53 как показателей агрессивности течения плоскоклеточного рака гортани. Вопросы онкологии 2007;53(1):668–73.
59. Лушников Е.Ф., Абросимов А.Ю. Гибель клетки (апоптоз). М.: Медицина, 2001. 190 с.
60. Ушаков В.С., Иванов С.В. Рак гортани: современные возможности и перспективы. Практическая онкология 2003;4(3):56–60.
61. Шилова О.Ю. Ассоциация рака гортани с вирусами папилломы человека и Эпштейна–Барр. Сибирский онкологический журнал 2007; Прил. 2. С. 126–27.
62. Шилова О.Ю., Уразова Л.Н. Молекулярно-генетические методы прогноза и течения рака гортани. Сибирский онкологический журнал 2010;5(41):64–70.
Рецензия
Для цитирования:
Горбань Н.А., Попучиев В.В., Барышев В.В. ПРОГНОСТИЧЕСКИЕ КРИТЕРИИ ТЕЧЕНИЯ ПЛОСКОКЛЕТОЧНОГО РАКА ГОРТАНИ (ОБЗОР ЛИТЕРАТУРЫ). Опухоли головы и шеи. 2013;(1):33-38. https://doi.org/10.17650/2222-1468-2013-0-1-33-38
For citation:
Gorban N.A., Popuchiev V.V., Baryshev V.V. PROGNOSTIC CRITERIA FOR THE COURSE OF SQUAMOUS CELL CARCINOMA OF THE LARYNX (A REVIEW OF LITERATURE). Head and Neck Tumors (HNT). 2013;(1):33-38. https://doi.org/10.17650/2222-1468-2013-0-1-33-38
Просмотров:
844
Послать статью по эл. почте 